trial
as of 2026-07-01D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia
NCTId NCT00963924
at a glance
— · Completed
Enrollment 54 (actual)
Sponsored by Massachusetts General Hospital
Primary completion 2011-05
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
54 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2009-08
Primary completion
2011-05
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Massachusetts General HospitalLead Sponsor
National Institute of Mental Health (NIMH)Collaborator
Investigators
1
Donald C. Goff, M.D.Principal Investigator
Sites
1 total
Boston, United States
Facts & assertions
4 sourced
Enrollment
54
Phase
NA
Primary Completion Date
2011-05
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
indication
indication
investigator
person